hims retatrutide FDA Blocks & Hers $49 Compounded Wegovy Pill: What to Know Retatrutide, an experimental weight-loss drug,

Earlier this week, the company Hims, arguably the best-known source of compounded GLP-1s, announced that it would stop marketing these drugs as part of a truce formed with Novo Nordisk

5 This figure is based on self-reported member data that has not been independently verified

Other GLP-1 drugs, including exenatide and dulaglutide, did not show the same benefit

We accept all major credit and debit cards (Visa, Mastercard, American Express, Discover) processed securely through our payment partner

While that gap is meaningful, it was not dramatic enough for AOD-9604 to win approval as a standalone obesity drug, and formal development was paused in 2007

So when a large new study hints at a link between GLP-1 receptor agonists and a rare but serious eye condition, it makes sense that people are nervous